Meridian Bioscience, Inc. (VIVO) financial statements and ratios from SEC XBRL: revenue $61000.00 (TTM), net margin -20970.5%, revenue growth 281.3% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $61000.00 |
| Net Margin | -20970.5% |
| Return on Equity | -63.6% |
| Debt / Equity | 0.84 |
| Current Ratio | 1.35 |
| Revenue Growth (YoY) | 281.3% |
| EPS Growth (YoY) | -87.3% |
| Price / Book | 2.72 |
| Price / Sales | 895.39 |
| Piotroski F-Score | 5/9 |
| Sector P/E (Utilities) | 20.8 |
VIVO overview · VIVO earnings · VIVO KPIs · VIVO investor relations · VIVO ownership · VIVO peers · VIVO filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.